Todd Harris, President and CEO at Tyra Biosciences, Inc. (TYRA), sold 112,352 shares at $26.98 ($2.9M) on 2024-10-16, disclosed to the SEC on 2024-10-17.
Scheduled sale ($2.9M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.31 | 10,035 | $244K | 8.4% |
| 2 | $24.31 | 10,035 | $244K | 8.4% |
| 3 | $25.22 | 4,900 | $124K | 4.3% |
| 4 | $26.23 | 24,475 | $642K | 22.2% |
| 5 | $26.23 | 24,475 | $642K | 22.2% |
| 6 | $26.98 | 3,922 |
| $106K |
| 3.7% |
| 7 | $26.98 | 3,922 | $106K | 3.7% |
| 8 | $25.84 | 15,194 | $393K | 13.5% |
| 9 | $25.84 | 15,194 | $393K | 13.5% |
| 10 | $26.37 | 200 | $5K | 0.2% |
| Total | $25.79 avg | 112,352 | $2.9M | 100% |
| Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |
| TYRA | SELL | 2024-02-06 | $3.3M | — | Filing → |